https://www.selleckchem.com/pr....oducts/Pancuronium-b
T2-low patients with severe asthma had significantly lower 24-hour cough frequency compared to T2-intermediate and T2-high patients. In patients with low biomarkers of T2 inflammation, cough frequency measurements were not elevated, suggesting that the mechanism for cough in asthma is underlying T2-eosinophilic inflammation and the logical first step for treating cough in asthma may be to achieve adequate suppression of T2 inflammation with currently available therapies. In patients with low biomarkers of T2 inflamm
Curtir
Comentario
Compartilhar
